Clearmind Medicine (CMND) Liabilities and Shareholders Equity (2021 - 2026)
Clearmind Medicine (CMND) reported Liabilities and Shareholders Equity of $14.52 million for fiscal Q2 2026 (quarter ended Apr 30, 2026), up 180.4% from $5.18 million a year earlier and up 30.3% from the prior quarter.
Powered by 
Analysis
Clearmind Medicine (CMND) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends
At the end of FY2024 (ended Oct 31, 2024), Clearmind Medicine posted Liabilities and Shareholders Equity of $7.26 million, up 21.9% from FY2023.
- Liabilities and Shareholders Equity has a three-year compound annual growth rate of 20.9% (FY2021 to FY2024).
- By fiscal year, Liabilities and Shareholders Equity came in at $5.95 million in FY2023 (+578.9%), $876,937 in FY2022 (-78.6%) and $4.1 million in FY2021.
- The fiscal Q2 2026 figure ranks as the highest quarterly Liabilities and Shareholders Equity in data going back to fiscal Q4 2021.
- Year over year, Liabilities and Shareholders Equity gained in four of the last seven quarters, with growth averaging 32.3%.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was fiscal Q4 2023 (growth of 601.0%); the low point was fiscal Q4 2022 (a decline of 79.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,164.36 Bn | 1,132.95 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 634.54 Bn | 553.07 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 502.85 Bn | 475.96 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 376.50 Bn | 330.88 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 303.65 Bn | 267.64 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 266.62 Bn | 240.30 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 241.17 Bn | 196.57 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 193.39 Bn | 167.59 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 172.45 Bn | 119.10 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Clearmind Medicine | 9,534.00 | -39.89 Mn | - | 16.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 16.91 Mn |
| Apr 30, 2026 | 14.52 Mn |
| Jan 31, 2026 | 11.14 Mn |
| Oct 31, 2025 | 6.08 Mn |
| Jul 31, 2025 | 3.97 Mn |
| Apr 30, 2025 | 5.18 Mn |
| Jan 31, 2025 | 6.58 Mn |
| Oct 31, 2024 | 7.26 Mn |
| Jul 31, 2024 | 8.17 Mn |
| Apr 30, 2024 | 8.85 Mn |
| Jan 31, 2024 | 10.10 Mn |
| Oct 31, 2023 | 5.95 Mn |
| Jul 31, 2023 | 4.49 Mn |
| Apr 30, 2023 | 6.00 Mn |
| Jan 31, 2023 | 4.64 Mn |
| Oct 31, 2022 | 828,898.94 |
| Oct 31, 2021 | 4.18 Mn |
API Access
Clearmind Medicine Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CMND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "CMND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CMND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();